Bildgebung beim intrahepatischen Cholangiokarzinom: Richtige Diagnostik nach der neuen S3-Leitlinie

Tobias Geith; Philipp M. Paprottka

doi:10.1007/s00117-021-00961-w

Bildgebung beim intrahepatischen Cholangiokarzinom: Richtige Diagnostik nach der neuen S3-Leitlinie

Translated title of the contribution: Imaging of intrahepatic cholangiocarcinoma: Reliable diagnosis according to the new S3 guideline

Tobias Geith, Philipp M. Paprottka

Associate Professorship of Department of Interventional Radiology

Technical University of Munich

Research output: Contribution to journal › Review article › peer-review

Abstract

The S3 guideline on hepatocellular carcinoma has been expanded to include malignant biliary carcinoma (synonym cholangiocarcinoma [CCA]). Magnetic resonance imaging (MRI) with additional magnetic resonance cholangiopancreatography (MRCP) is the imaging modality of choice to evaluate local findings. Use of gadolinium ethoxybenzyl diethylenetriamine penta‐acetic acid (Gd‐EOB‐DTPA)-based contrast agent increases its diagnostic value. Histologic confirmation is always required when diagnosing intrahepatic CCA (iCCA) because using imaging alone there is a risk of confusion with HCC subtypes.

Translated title of the contribution	Imaging of intrahepatic cholangiocarcinoma: Reliable diagnosis according to the new S3 guideline
Original language	German
Pages (from-to)	205-209
Number of pages	5
Journal	Radiologe
Volume	62
Issue number	3
DOIs	https://doi.org/10.1007/s00117-021-00961-w
State	Published - Mar 2022

Access to Document

10.1007/s00117-021-00961-w

Cite this

@article{d340694f49e847c2afc022d154b3176e,

title = "Bildgebung beim intrahepatischen Cholangiokarzinom: Richtige Diagnostik nach der neuen S3-Leitlinie",

abstract = "The S3 guideline on hepatocellular carcinoma has been expanded to include malignant biliary carcinoma (synonym cholangiocarcinoma [CCA]). Magnetic resonance imaging (MRI) with additional magnetic resonance cholangiopancreatography (MRCP) is the imaging modality of choice to evaluate local findings. Use of gadolinium ethoxybenzyl diethylenetriamine penta‐acetic acid (Gd‐EOB‐DTPA)-based contrast agent increases its diagnostic value. Histologic confirmation is always required when diagnosing intrahepatic CCA (iCCA) because using imaging alone there is a risk of confusion with HCC subtypes.",

keywords = "Cholangiocarcinoma, Cholangiopancreatography, Diagnostic imaging, Liver cirrhosis, Liver neoplasms",

author = "Tobias Geith and Paprottka, {Philipp M.}",

note = "Publisher Copyright: {\textcopyright} 2022, The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.",

year = "2022",

month = mar,

doi = "10.1007/s00117-021-00961-w",

language = "Deutsch",

volume = "62",

pages = "205--209",

journal = "Radiologe",

issn = "0033-832X",

publisher = "Springer Medizin",

number = "3",

}

TY - JOUR

T1 - Bildgebung beim intrahepatischen Cholangiokarzinom

T2 - Richtige Diagnostik nach der neuen S3-Leitlinie

AU - Geith, Tobias

AU - Paprottka, Philipp M.

PY - 2022/3

Y1 - 2022/3

N2 - The S3 guideline on hepatocellular carcinoma has been expanded to include malignant biliary carcinoma (synonym cholangiocarcinoma [CCA]). Magnetic resonance imaging (MRI) with additional magnetic resonance cholangiopancreatography (MRCP) is the imaging modality of choice to evaluate local findings. Use of gadolinium ethoxybenzyl diethylenetriamine penta‐acetic acid (Gd‐EOB‐DTPA)-based contrast agent increases its diagnostic value. Histologic confirmation is always required when diagnosing intrahepatic CCA (iCCA) because using imaging alone there is a risk of confusion with HCC subtypes.

AB - The S3 guideline on hepatocellular carcinoma has been expanded to include malignant biliary carcinoma (synonym cholangiocarcinoma [CCA]). Magnetic resonance imaging (MRI) with additional magnetic resonance cholangiopancreatography (MRCP) is the imaging modality of choice to evaluate local findings. Use of gadolinium ethoxybenzyl diethylenetriamine penta‐acetic acid (Gd‐EOB‐DTPA)-based contrast agent increases its diagnostic value. Histologic confirmation is always required when diagnosing intrahepatic CCA (iCCA) because using imaging alone there is a risk of confusion with HCC subtypes.

KW - Cholangiocarcinoma

KW - Cholangiopancreatography

KW - Diagnostic imaging

KW - Liver cirrhosis

KW - Liver neoplasms

UR - http://www.scopus.com/inward/record.url?scp=85123119107&partnerID=8YFLogxK

U2 - 10.1007/s00117-021-00961-w

DO - 10.1007/s00117-021-00961-w

M3 - Übersichtsartikel

C2 - 35029722

AN - SCOPUS:85123119107

SN - 0033-832X

VL - 62

SP - 205

EP - 209

JO - Radiologe

JF - Radiologe

IS - 3

ER -

Bildgebung beim intrahepatischen Cholangiokarzinom: Richtige Diagnostik nach der neuen S3-Leitlinie

Abstract

Access to Document

Other files and links

Fingerprint

Cite this